Our investigations revealed de novo GRIN2B missense mutations in 2 of 91patients with unexplained EE (2.2%) and in 1 patient with ID and childhood onset focalepilepsy. This evidence concerns the gene GRIN2B and ethylmalonic encephalopathy.